Blog
Bem-vindo ao nosso blog - seu novo canal de informações para notícias, lançamento de produtos, artigos científicos, estudos de caso e muito mais.
![lab image](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/shutterstock-1409819669.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=C126FD94AB1C286352DF7AFD46CBF760)
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
![child being vaccinated](/mediaassets/images/health-care/health-care-new-website/news-images/shutterstock-277383209.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=55A541A47F7DE434825A1FAFF4687108)
Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
![woman in lab dropping liquid into test tube with purple wash over image](/mediaassets/images/health-care/health-care-new-website/virodex/3.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=406CD13B5341FF79113F334ADFFF645F)
Specializing in specific enhancement technologies
Croda Pharma specializes in four technologies aimed at improving bioavailability and solubility. Find out more!
![scientist looking at tray in lab](/mediaassets/images/health-care/virodex.png?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=91384885174910DC8D337A4777AA42CC)
Concerns about Triton™ X-100 have been an ongoing discussion across multiple regulatory authorities around the world
Triton™ X-100, a non-ionic surfactant with a hydrophilic polyethylene oxide chain and a hydrophobic aromatic group1, has found widespread use in the biopharmaceutical industry with applications...
![World Cancer Day Banner](/mediaassets/images/health-care/health-care-new-website/banners/wcd.png?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=F7D839D0117267EFC8E999709963193B)
“Close the Care Gap” – World Cancer Day 2024
We are proud to continue supporting the development of cancer treatments, and on this World Cancer Day, recognise the importance of innovation and science to cure and treat those diagnosed. Together,...
![Kritika Bajaj, Croda Pharma](/mediaassets/images/health-care/health-care-new-website/authors-and-headshots/kritika-bajaj-5g5a3416.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=0D76C476B6291F27496544E53060EEDA)
Spotlight on Kritika Bajaj
Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...
![lipid nanoparticle cross section](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/lnp-cross-section-1-nad-filter.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=46D30FBE4FF09B20396A53752C21B462)
Innovative lipids for your nucleic acid delivery research
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
![Adjuvant systems](/mediaassets/images/health-care/health-care-new-website/technology-platforms/icons/adjuvant-systems.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=A8BD9C3ECCA858376D148581DEBBBDCB)
Introducing our Adjuvant Systems Platform
Introducing our Adjuvant Systems platform. Leveraging a history of developing adjuvants since 1939, our scientists deliver high performance adjuvants to meet your vaccine needs today.
![Small molecule delivery](/images/blank.png)
Introducing our Small Molecule Delivery platform
Our offering for Small Molecule Delivery focuses on tackling your formulation challenges and enhancing drug delivery through our high purity Super Refined™ excipients. Over the years, enhancing...
![liposome cross section image](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/liposome-cross-section-nad-filter.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=4D6D734E5BA759B69E70E65298F5978A)
The future of mRNA delivery: Advancements in engineering lipid nanoparticles for enhanced intracellular delivery through inhalation
Messenger RNA (mRNA) has played a crucial role in recent vaccine developments and is at the forefront of much current medical research. Traditionally. the delivery of mRNA systemically via lipid...
![headshot of Dennis Christenson](/mediaassets/images/health-care/health-care-new-website/authors-and-headshots/dennis-christenson.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=2701235ED361D245D10818040BC17C08)
Lipid Leaders: Dennis Christensen
In this Lipid Leaders interview, we get insight from Croda Pharma's own Global Head of R&D - Adjuvant Systems, Dennis Christensen, PhD. Keep reading to learn more about adjuvants and the role they...
![test tube and flask in medical chemistry](/mediaassets/images/health-care/health-care-new-website/resources/shutterstock-1879988884.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=0F45D29E6B62154821BEC2D93EC53493)
A abordagem da Croda para a Iniciativa de Mercados Sustentáveis para metas de sustentabilidade de fornecedores
A recente declaração pública do Grupo de Trabalho para Sistemas de Saúde da Iniciativa para os Mercados Sustentáveis apelou para que as cadeias de abastecimento de cuidados de saúde adotassem práticas...
![Vaccine shown over map image](/mediaassets/images/health-care/health-care-new-website/banners/sustainable-vaccines-2.png?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=015B40AD80075A4F183F78B487D3AFC5)
Sustentabilidade em vacinas: Descarbonização de uma de nossas principais instalações
Sustentabilidade frequentemente é definida como o atendimento das necessidades das gerações atuais sem comprometer a capacidade das gerações futuras de atenderem às suas próprias necessidades. Este é...
![lipid nanoparticle cross section](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/lnp-cross-section-1-nad-filter.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=46D30FBE4FF09B20396A53752C21B462)
A powerful match - celebrating three years of Croda Pharma and Avanti
Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...
![woman in lab dropping liquid into test tube with purple wash over image](/mediaassets/images/health-care/health-care-new-website/virodex/3.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=406CD13B5341FF79113F334ADFFF645F)
Introducing new bioprocessing solutions to replace banned materials
We have introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need...
![liposome cross section image](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/liposome-cross-section-nad-filter.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=4D6D734E5BA759B69E70E65298F5978A)
Cholesterol: enhancing stability and efficacy in lipid-based drug delivery
Cholesterol, a key component in lipid-based drug delivery systems, provides structural support and stability, enhances the efficiency of intracellular delivery and gene transfection.
![Solus acquisition](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/solus-image.png?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=417A43E2888EDA6E236E12BAF21F88B9)
Acquisition of Solus Biotech expands specialised Pharma business in Asia
05 July 2023: Croda International Plc (‘Croda’) announced that it has acquired Solus Biotech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials
![Solus manufacturing site](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/solus-manufacturing-site.png?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=76590C2F3D68867D9CB33FE7D20623E6)
Acquisition of Solus Biotech strengthens Croda Pharma
On 04 July Croda successfully completed the acquisition of Solus Biotech, an innovative biotechnology company with over three decades of industry experience.
![Daniele Piergentili ribbon cutting](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/img-0343.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=222AF5B106D0E49E8784E02200712534)
Croda opens new Global Technical Centre at Genome Valley, Hyderabad, India
PRESS RELEASE – On June 21, 2023, Croda International Plc opened its new Global Technical Centre at Genome Valley, Hyderabad, India.
![Image of Croda employees, breaking ground at new site in Lamar, Pennsylvania](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/lamar-groundbreaking.jpg?w=768&la=pt-BR&focalpointcrop=1&xratio=0&yratio=0&hash=77B315707709CC6C962B4E38D8C4DBFD)
Croda breaks ground on new manufacturing facility for pharmaceutical excipients in Lamar, Pennsylvania
31st May 2023: Croda, Inc., the company that uses smart science to create high-performance ingredients and solutions that improve lives, broke ground on 9 May 2023, its newest manufacturing facility...